Overview In Second Quarter 2024 Italia Centrale exported $25.3B and imported $23.3B, resulting in a positive trade balance of $2.04B. Between Second Quarter 2023 and Second Quarter 2024 the exports of Italia Centrale have increased by $1.6B (6.76%) from $23.7B to $25.3B, while imports increased by $1.65B (7.65%) from $21.6B to $23.3B.
Trade In Second Quarter 2024, the top exports of Italia Centrale were Basic pharmaceutical products and pharmaceutical preparations (€6.42B), Machinery and equipment nec (€2.52B), Products from other manufacturing industries (€2.45B), Metallurgy products (€1.8B), and Leather goods (excluding clothing) and similar (€1.62B). In Second Quarter 2024 the top imports of Italia Centrale were Basic pharmaceutical products and pharmaceutical preparations (€5.71B), Metallurgy products (€2.97B), Motor vehicles, trailers and semi-trailers (€1.91B), Food products (€1.24B), and Coke and products derived from petroleum... (€1.22B).
Destinations In Second Quarter 2024, Italia Centrale exported mostly to United States (€4.12B), Germany (€2.81B), Belgium (€2.04B), Turkey (€1.77B), and Netherlands (€1.55B), and imported mostly from Germany (€2.71B), United States (€2.7B), Belgium (€2.02B), Spain (€1.98B), and China (€1.48B).
Growth In Second Quarter 2024, the increase in Italia Centrale's year-by-year exports was explained primarily by an increase in exports to Turkey (€1.18B or 200%), United States (€887M or 27.5%), and Netherlands (€369M or 31.3%), and product exports increase in Basic pharmaceutical products and pharmaceutical preparations (€1.19B or 22.8%), Products from other manufacturing industries (€1.14B or 86.7%), and Food products (€218M or 29.2%). In Second Quarter 2024, the increase in Italia Centrale's year-by-year imports was explained primarily by an increase in imports from United States ($1.12B or 70.7%), Spain ($396M or 25%), and Canada ($229M or 187%), and product imports increase in Basic pharmaceutical products and pharmaceutical preparations (€1.54B or 36.9%), Metallurgy products (€649M or 28%), and Coke and products derived from petroleum... (€312M or 34.6%).